Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
暂无分享，去创建一个
F. Davi | P. Karoyan | K. Maloum | E. Chapiro | F. Nguyen‐Khac | H. Merle-Béral | D. Decaudin | F. Némati | M. Sarfati | É. Pramil | S. Susin | M. Le Garff-Tavernier | D. Roos‐Weil | Malina Xiao | Linda Herbi Bastian | Thomas Denèfle | Eva Lardé | D. Roos-Weil | E. Pramil